Arachidonic Acid Market Size

Arachidonic Acid Market size was valued at USD 231.61 Billion in 2023 and is poised to grow from USD 241.8 Billion in 2024 to USD 341.24 Billion by 2032, growing at a CAGR of 4.4% during the forecast period (2025-2032).

The increasing awareness among consumers regarding baby care products has become a driving force behind the growth of the arachidonic acid industry. Additionally, there is a growing demand for these products to aid in the healing of critical physical injuries, further contributing to the industry's expansion. The benefits of ARA include improved visual acuity, balanced levels of phosphate and calcium, enhanced neuron growth, and promotion of cell survival in developing infants.

To enhance product quality and brand value, key manufacturers in the industry are focusing on improving in-house manufacturing techniques and conducting extensive research and development activities. The cost of producing ARA is falling as a result of factors like population expansion, growing income levels, greater awareness, and the creation of cutting-edge technologies.

This reduction is expected to drive arachidonic acid industry growth in the foreseeable future. Arachidonic acid, belonging to the Omega-6 group, is an essential fatty acid that holds significance due to its storage within cell membranes and its role in signaling adaptive changes in response to damage. In cases where the body lacks sufficient natural arachidonic acid, additional intake is required through injections, syrups, or tablets. Corn, glucose, soy, yeast, and other materials are commonly used as primary raw materials in the production of ARA.

Companies engaged in the manufacturing of infant formula are actively striving to enhance consumer awareness through various educational campaigns. These collective efforts are anticipated to positively impact the arachidonic acid market growth as a whole.

US Arachidonic Acid Market is poised to grow at a sustainable CAGR for the next forecast year.